跳至主要内容
临床试验/ACTRN12605000639628
ACTRN12605000639628已完成3 期

A prospective, double-blind randomised control study comparing the effect of atenolol versus placebo on mortality and cardiovascular morbidity in patients undergoing non-cardiac surgery.

Department of Anaesthesia, St Vincent's Hospital, Melbourne0 个研究点目标入组 200 人开始时间: 2005年10月13日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
ot stated 至 ot stated(—)
性别
All

入选标准

  • Any patient undergoing major surgery under general anaesthesia who has at least 2 of the following risk factors for coronary artery disease: diabetes, hypertension, current smoker, cholesterol > 6.2mmol/L.

排除标准

  • Known coronary artery disease, long term beta-blocker use, poorly compensated CCF, 3rd degree heart block, inducible bronchospasm (unstable asthma).

研究者

发起方
Department of Anaesthesia, St Vincent's Hospital, Melbourne

相似试验